Home testing firm LetsGetChecked announced on Tuesday that its ImPress lancing device has received 510(k) clearance from the US Food and Drug Administration for professional use. The single-use blood ...

According to the DOJ, a jury found that New York City-based Alexander Baldonado received tens of thousands of dollars in illegal cash kickbacks and bribes in exchange for ordering genetic cancer tests ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

Demand remains low, but lab stakeholders said the industry is significantly better prepared to meet a spike in H5N1 testing ...

NEW YORK – Drawing on its longstanding partnership with Becton Dickinson, Babson Diagnostics is aiming to further expand use of its US Food and Drug Administration-cleared blood collection system ...

Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

The prognostic test stratifies hospitalized women with hypertensive disorders of pregnancy into low- and high-risk categories for developing severe preeclampsia.

The company was in violation of the stock exchange's requirements for the minimum bid price and the market value of listed securities.

NEW YORK – Digital pathology software startup Aiosyn said that it plans to double its head count and create new product-specific teams as the firm ramps up the commercialization in Europe of its tool ...